---
title: "Ideaya Biosciences Insider Bought Shares Worth $1,647,890, According to a Recent SEC Filing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277589490.md"
description: "03:27 AM EST, 03/03/2026 (MT Newswires) -- Jeffrey Stein, Director, on March 02, 2026, executed a purchase for 50,000 shares in Ideaya Biosciences ( IDYA ) for $1,647,890. Following the Form 4 filing with the SEC, Stein has control over a total of 61,007 common shares of the company, with 54,281 shares held directly and 6,726 controlled indirectly.SEC Filing: MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited."
datetime: "2026-03-03T08:27:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277589490.md)
  - [en](https://longbridge.com/en/news/277589490.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277589490.md)
---

# Ideaya Biosciences Insider Bought Shares Worth $1,647,890, According to a Recent SEC Filing

03:27 AM EST, 03/03/2026 (MT Newswires) -- Jeffrey Stein, Director, on March 02, 2026, executed a purchase for 50,000 shares in Ideaya Biosciences ( IDYA ) for $1,647,890. Following the Form 4 filing with the SEC, Stein has control over a total of 61,007 common shares of the company, with 54,281 shares held directly and 6,726 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1676725/000161071726000078/xslF345X05/form4.xml

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [IDYA.US](https://longbridge.com/en/quote/IDYA.US.md)

## Related News & Research

- [BUZZ-IDEAYA rises after lung cancer drug combo testing deal with AstraZeneca](https://longbridge.com/en/news/282173989.md)
- [IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Consensus Recommendation of "Moderate Buy" by Brokerages](https://longbridge.com/en/news/279565337.md)
- [Did IDEAYA’s (IDYA) First-in-Human IDE034 Trial Just Redefine Its Targeted Oncology Strategy?](https://longbridge.com/en/news/277609384.md)
- [IDEAYA Biosciences Teases End-of-March Data for Darovasertib Combo at Citi Oncology Summit](https://longbridge.com/en/news/276632492.md)
- [IDEAYA Biosciences, Inc. $IDYA Stake Lifted by SG Americas Securities LLC](https://longbridge.com/en/news/272895771.md)